aTyr Pharma, Inc.ATYRNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank85
3Y CAGR+24.7%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+24.7%/yr
Annual compound
Percentile
P85
Within normal range
vs 3Y Ago
1.9x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 27.73% |
| 2024 | 6.15% |
| 2023 | 5.63% |
| 2022 | 14.29% |
| 2021 | 18.47% |
| 2020 | -2.96% |
| 2019 | -19.99% |
| 2018 | -28.57% |
| 2017 | 15.30% |
| 2016 | 8.25% |